Skip to main content
Article thumbnail
Location of Repository

The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-kB inhibitor ABIN-2

By David P. Hughes, Marie B. Marron and Nicholas P.J. Brindle


Tie2 is a receptor tyrosine kinase expressed predominantly in endothelial cells and is essential for blood vessel formation and maintenance. The receptor has potent antiinflammatory effects on endothelial cells, suppressing vascular endothelial growth factor– and tumor necrosis factor–induced expression of leukocyte adhesion molecules and procoagulant tissue factor and inhibiting vascular leakage. To delineate the signaling pathways utilized by Tie2, we performed yeast two-hybrid screening of a human endothelial cell cDNA library and identified a novel protein interacting with the intracellular domain of the receptor. This protein was found to be human A20 binding inhibitor of NF-κB activation-2, ABIN-2, an inhibitor of NF-κB–mediated inflammatory gene expression. Coexpression of Tie2 and ABIN-2 in CHO cells confirmed the interaction occurs in mammalian cells. In contrast, Tie1 did not interact with ABIN-2 in the yeast two-hybrid system or mammalian cells. Deletion analysis identified the Tie2 binding motif to be encompassed between residues 171 and 272 in ABIN-2. Interaction was dependent on Tie2 autophosphorylation but ABIN-2 was not tyrosine phosphorylated by Tie2. Furthermore, in endothelial cells the interaction was stimulated by the Tie2 ligand angiopoietin-1. Expression of ABIN-2 deletion mutants in endothelial cells suppressed the ability of angiopoietin-1 to inhibit phorbol ester–stimulated NF-κB–dependent reporter gene activity. These findings provide the first direct link between Tie2 and a key regulator of inflammatory responses in endothelial cells. Interaction between Tie2 and ABIN-2 may be important in the vascular protective antiinflammatory actions of Tie2.Peer-reviewedPublisher Versio

Publisher: American Heart Association, Inc.
Year: 2003
DOI identifier: 10.1161/01.RES.0000063422.38690.DC
OAI identifier:

Suggested articles


  1. (2001). Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol.
  2. (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. doi
  3. (1996). Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. doi
  4. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.
  5. (1999). 4: diverging gene counterparts in mice and humans. doi
  6. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. doi
  7. (1998). Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol. doi
  8. (1999). Role of PI 3-kinase in angiopoietin-1–mediated migration and attachment-dependent survival of endothelial cells. Exp Cell Res. doi
  9. (1999). Identification of Tek/Tie2 binding partners: binding to a multifunctional docking site mediates cell survival and migration. doi
  10. (2000). Angiopoietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasmin secretion. Circ Res. doi
  11. (1999). Vessel cooption, regression, and growth in tumors mediated by angiopoietins
  12. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3-kinase/Akt signal transduction pathway. doi
  13. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/Survivin pathway.
  14. Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. doi
  15. (1998). Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol. doi
  16. (1998). The Tek/Tie2 receptor signals through a novel Dok-related docking protein, doi
  17. Dok-R plays a pivotal role in angiopoietin-1– dependent cell migration through recruitment and activation of Pak. doi
  18. GRB2 and SH-PTP2:potentially important endothelial signaling molecules downstream of the TEK/TIE2 receptor tyrosine kinase.
  19. (1999). Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. doi
  20. (2000). Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med. doi
  21. (2000). Angiopoietin-1 is an antipermeability and antiinflammatory agent in vitro and targets cell junctions. Circ Res. doi
  22. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-Selectin expression. Circ Res. doi
  23. Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells.
  24. Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2. doi
  25. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest.
  26. (1996). Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast.
  27. The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells. doi
  28. (1985). Enhanced chemiluminescent method for the detection of DNA dot-hybridization assays. Anal Biochem. doi
  29. (1995). Predicting coiled coils by use of pairwise residue correlations. doi
  30. Identification of a novel A20-binding inhibitor of nuclear factor-B activation termed ABIN-2. doi
  31. (1996). A20 blocks endothelial cell activation through a NF-B–dependent mechanism. doi
  32. Tumor necrosis factor- induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin.
  33. (1992). Transcriptional activation of the tumor necrosis factor-–inducible zinc finger protein, A20, is mediated by B elements.
  34. Failure to regulate TNF-induced NF-B and cell death responses in A20-deficient mice.
  35. Functional redundancy of the zinc fingers of A20 for inhibition of NF-B activation and protein-protein interactions. doi
  36. (2003). The zinc finger protein A20 inhibits TNF-induced NF-B-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-B–inhibiting protein ABIN. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.